A detailed history of Shell Asset Management CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 63,664 shares of MRK stock, worth $6.47 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
63,664
Previous 64,777 1.72%
Holding current value
$6.47 Million
Previous $8.02 Million 9.84%
% of portfolio
0.32%
Previous 0.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$111.15 - $128.97 $123,709 - $143,543
-1,113 Reduced 1.72%
63,664 $7.23 Million
Q1 2024

Jul 31, 2024

SELL
$113.24 - $131.95 $708,316 - $825,347
-6,255 Reduced 8.81%
64,777 $8.02 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $646,940 - $753,830
5,713 Added 8.75%
71,032 $9.37 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $1.66 Million - $1.81 Million
-16,617 Reduced 20.28%
65,319 $7.12 Million
Q3 2023

Nov 08, 2023

SELL
$102.95 - $114.33 $124,981 - $138,796
-1,214 Reduced 1.46%
81,936 $8.44 Million
Q2 2023

Jul 28, 2023

SELL
$108.61 - $118.38 $1.2 Million - $1.31 Million
-11,033 Reduced 11.71%
83,150 $9.6 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $331,157 - $369,504
-3,217 Reduced 3.3%
94,183 $10 Million
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $1.68 Million - $2.16 Million
-19,270 Reduced 16.52%
97,400 $10.8 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2.31 Million - $2.6 Million
-27,365 Reduced 19.0%
116,670 $10 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $586,183 - $664,467
7,021 Added 5.12%
144,035 $13.1 Million
Q1 2022

May 04, 2022

SELL
$73.51 - $82.4 $332,118 - $372,283
-4,518 Reduced 3.19%
137,014 $11.2 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $1.24 Million - $1.55 Million
-17,115 Reduced 10.79%
141,532 $10.8 Million
Q3 2021

Nov 04, 2021

SELL
$71.68 - $78.83 $8.17 Million - $8.98 Million
-113,922 Reduced 41.8%
158,647 $11.9 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $764,480 - $845,593
-10,873 Reduced 3.84%
272,569 $21.2 Million
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $2.69 Million - $3.17 Million
-39,099 Reduced 12.12%
283,442 $21.9 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $299,639 - $332,538
4,175 Added 1.31%
322,541 $26.4 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $179,876 - $203,891
-2,458 Reduced 0.77%
318,366 $26.4 Million
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $447,730 - $509,466
6,358 Added 2.02%
320,824 $24.8 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $1.4 Million - $1.94 Million
-22,147 Reduced 6.58%
314,466 $24.2 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $1.37 Million - $1.54 Million
-17,634 Reduced 4.98%
336,613 $30.6 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $1.38 Million - $1.51 Million
-18,150 Reduced 4.87%
354,247 $29.8 Million
Q2 2019

Aug 12, 2019

SELL
$69.84 - $81.59 $1.18 Million - $1.38 Million
-16,946 Reduced 4.35%
372,397 $31.2 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $1.81 Million - $2.07 Million
-26,076 Reduced 6.28%
389,343 $32.4 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $6.14 Million - $7.13 Million
-94,166 Reduced 18.48%
415,419 $31.7 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $1.24 Million - $1.45 Million
-21,424 Reduced 4.03%
509,585 $36.2 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $4.41 Million - $5.18 Million
-86,798 Reduced 14.05%
531,009 $32.2 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $866,370 - $1.01 Million
17,001 Added 2.83%
617,807 $33.7 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $3.97 Million - $4.74 Million
76,852 Added 14.67%
600,806 $33.8 Million
Q3 2017

Oct 20, 2017

SELL
$58.67 - $63.13 $29.6 Million - $31.9 Million
-504,836 Reduced 49.07%
523,954 $33.5 Million
Q3 2017

Oct 18, 2017

BUY
$58.67 - $63.13 $60.4 Million - $64.9 Million
1,028,790
1,028,790 $61 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.